2nd Quarter - Amendment — AMERICAN CANCER SOCIETY CANCER ACTION N… for AMERICAN CANCER SOCIETY CANCER ACTION N… (2021)

Firm

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.

Client

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC

Income

—

Expenses

$660,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
2nd Quarter - Report	Jul 20, 2021	$660,000	Replaced
2nd Quarter - Amendment (this page)	Jan 6, 2022	$660,000	Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Issues regarding expanding the availability of the charitable deduction for non-itemizers, issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. WORK NOW Act, HR 1987, S 740 Legacy IRA Act, HR 3832, S. 243

Lobbyist	Covered position, as disclosed
ROSALIE ABBOTT	—
OKEYSHA BROOKS-COLEY	—
ILHAAM JAFFER New	—
STEPHANIE KRENRICH	—
CAROLINE POWERS	—

Contacted: Federal Trade Commission (FTC); State, Dept of (DOS); Transportation, Dept of (DOT); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Labor, Dept of (DOL); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Energy, Dept of; HOUSE OF REPRESENTATIVES; White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); Federal Reserve System; Veterans Affairs, Dept of (VA)

Bills named: S. 243 (117th), H.R. 3832 (117th), H.R. 1987 (117th)

Health Issues HCR

Issues relating to access to care, health disparities, childhood cancer, quality of life and palliative care, cancer survivorship, federal health care programs, genetic information, cancer, nutrition, tanning beds, clinical trials, skin cancer, cannabis research, and wellness, including: HR 1550, The Prevent HPV Cancers Act S 464/HR 2163 Safe Step Act S. 699, Women and Lung Cancer Research and Preventive Services Act of 2021 HR 623, Gabriella Miller Kids First Research Act 2.0 The Palliative Care and Hospice Education and Training Act (soon to be introduced) Issues related to the proposed HELP workforce proposal. Issues related to the possible introduction of the 21st Century Cures Act version 2.0 Regulations implementing the No Suprises Act OMB RFI on health equity - comments ACA subsidies expansion permanency - next legislative package Advocacy around subpar health plans - next legislative package DICT RFI - Eshoo DICT Ancillary Costs legislation/Menendez, Scott, Smith, Young, Ruiz House/Senate Appropriations Committee FDA DICT report language Reducing Hereditary Cancer Act of 2021 - DWS, Slotkin, Miller-Meeks, and Davis Personal Care Products Safety Act - Feinstein, Collins H.R. 6638 - Reducing COVID-19 Disparities by Investing in Public Health Act of 2021 The VALID Act - DeGette, Bennet, Burr, Buschon

Lobbyist	Covered position, as disclosed
ROSALIE ABBOTT	—
OKEYSHA BROOKS-COLEY	—
ILHAAM JAFFER New	The White House, Office of Scheduling and Advance, Advance Associate 2013 -2015; U.S. House of Representatives,Congresswoman Eddie Bernice Johnson (TX-30)Deputy Chief of staff, Policy Advisor, 2006-2013.
STEPHANIE KRENRICH	—
CAROLINE POWERS	—

Contacted: Food & Drug Administration (FDA); SENATE; State, Dept of (DOS); Centers For Disease Control & Prevention (CDC); Federal Reserve System; Small Business Administration (SBA); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); Labor, Dept of (DOL); Federal Trade Commission (FTC); Energy, Dept of; White House Office; Health & Human Services, Dept of (HHS); Veterans Affairs, Dept of (VA); Treasury, Dept of

Bills named: H.R. 1550 (117th), S. 699 (117th), H.R. 623 (117th), H.R. 2163 (117th), H.R. 6638 (117th)

Medicare/Medicaid MMM

Issues related to implementation of legislative or regulatory changes to Medicare and Medicaid, including: HR 1946, Multi Cancer Early Detection Screening Coverage Act HR 2594, To amend title XVIII of the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests furnished under the Medicare program. S. 245, SAME Act of 2021 HR 340, the Incentivizing Medicaid Expansion Act HR 66, the Comprehensive Access to Robust Insurance Now Guaranteed for Kids Act HR 1791, the Childrens Health Insurance Permanency Act Issues related to governance of state Medicaid programs, including work requirements and block grant proposals. Issues related to the waiting period for SSDI and Medicare. Home and Community Based Services Access Act Policy issues related to coverage for low-income populations in states that have not yet expanded their Medicaid programs (coverage gap) Cancer Care Planning and Communications Act, HR 4414 CONNECT Act (telehealth), S. 1512 Lymphedema Treatment Act, HR 3630, S. 1315 Bipartisan Seniors Prescription Drug Relief Act - Cassidy/Menendez Expanding Access to Affordable Prescription Drugs and Medical Devices Act - Rosen

Lobbyist	Covered position, as disclosed
ROSALIE ABBOTT	—
OKEYSHA BROOKS-COLEY	—
ILHAAM JAFFER New	The White House, Office of Scheduling and Advance, Advance Associate 2013 -2015; U.S. House of Representatives,Congresswoman Eddie Bernice Johnson (TX-30)Deputy Chief of staff, Policy Advisor, 2006-2013.
STEPHANIE KRENRICH	—
CAROLINE POWERS	—

Contacted: Centers For Disease Control & Prevention (CDC); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Energy, Dept of; State, Dept of (DOS); Transportation, Dept of (DOT); Labor, Dept of (DOL); White House Office; Treasury, Dept of; SENATE; Federal Reserve System; Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Small Business Administration (SBA); Natl Institutes of Health (NIH); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA)

Bills named: S. 1512 (117th), H.R. 66 (117th), H.R. 1791 (117th), H.R. 340 (117th), H.R. 4414 (117th), H.R. 1946 (117th), H.R. 2594 (117th), H.R. 3630 (117th), S. 245 (117th), S. 1315 (117th)

Budget/Appropriations BUD

FY 2022 federal appropriations for cancer research and prevention funding at the NIH, NCI and CDC; emergency funding to restart COVID-19 impacted cancer research and clinical trials at the NIH; policy issues and funding related to the CDCs and FDAs tobacco work; issues and funding related to non-communicable diseases; ; issues related to highway authorization and appropriations, and issues related to funding of domestic medical isotope molybdenum-99 (Mo-99) program at the Department of Energy (DOE). HR 869/S. 289 RISE Act of 2021 S.962 - A bill to prioritize funding for an expanded and sustained national investment in biomedical research. Issues related to appropriations for consumer assistance programs, under the Labor, Health and Human Services appropriations bill. HR 2786/S. 1314 - Tobacco Tax Equity Act of 2021 Cures 2.0 RFI - DeGette, Upton ARPA-H Principles

Lobbyist	Covered position, as disclosed
ROSALIE ABBOTT	—
OKEYSHA BROOKS-COLEY	—
ILHAAM JAFFER New	The White House, Office of Scheduling and Advance, Advance Associate 2013 -2015; U.S. House of Representatives,Congresswoman Eddie Bernice Johnson (TX-30)Deputy Chief of staff, Policy Advisor, 2006-2013.
STEPHANIE KRENRICH	—
CAROLINE POWERS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Small Business Administration (SBA); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Federal Trade Commission (FTC); Centers For Disease Control & Prevention (CDC); Transportation, Dept of (DOT); Natl Institutes of Health (NIH); White House Office; Health & Human Services, Dept of (HHS); Federal Reserve System; Treasury, Dept of; Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); State, Dept of (DOS); Energy, Dept of; U.S. Agency for International Development (USAID); Labor, Dept of (DOL)

Bills named: H.R. 2786 (117th), S. 962 (117th), S. 1314 (117th), H.R. 869 (117th), S. 289 (117th)

Tobacco TOB

Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments, including: Implementation of the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31), including the FDA deeming regulation; Issues relating to FDA regulation of menthol, flavors, electronic cigarettes and cigars; HR 2125, The Quit Because of COVID Act HR 2786/S 1314 - Tobacco Tax Equity Act of 2021 The Protect Act

Lobbyist	Covered position, as disclosed
ROSALIE ABBOTT	—
OKEYSHA BROOKS-COLEY	—
ILHAAM JAFFER	—
CAROLINE POWERS	—

Contacted: Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); Treasury, Dept of; White House Office; Natl Institutes of Health (NIH); Federal Reserve System; Environmental Protection Agency (EPA); Energy, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Transportation, Dept of (DOT); Labor, Dept of (DOL); Small Business Administration (SBA); Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); SENATE; Federal Trade Commission (FTC); State, Dept of (DOS); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 2786 (117th), H.R. 2125 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.